Methods and compositions for secretion of heterologous polypeptides

• US 5,840,523 A
• Filed: 03/01/1995
• Issued: 11/24/1998
• Est. Priority Date: 03/01/1995
• Status: Expired due to Term

• Current Assignee: Genentech, Inc. (Roche Holding AG)
• Original Assignee: Genetec Incorporated (Noritsu Koki Co., Ltd.)
• Inventors: Simmons, Laura C., Yansura, Daniel G.
• Primary Examiner(s): LEITH, NANCY J
• Application Number:
  US08/398,615
• Time in Patent Office: 1,364 Days
• Field of Search: 435/6, 435/69.1, 435/172.3, 536/23.7, 536/24.1
• US Class Current: 435/69.1
• CPC Class Codes: C07K 14/245 Escherichia (G)
• CPC Class Codes: C07K 2319/02 containing a signal sequence
• CPC Class Codes: C07K 2319/61 containing an enzyme fusion for detection (lacZ, luciferase)
• CPC Class Codes: C12N 15/625 containing a sequence coding for a signal sequence
• CPC Class Codes: C12N 15/70 Vectors or expression systems specially adapted for E. coli

Abstract

The instant invention discloses the unexpected result that mutant signal sequences with reduced translational strength provided essentially complete processing and high levels of expression of a polypeptide of interest as compared to wild type signal sequences, and that many mammalian polypeptides require a narrow range of translation levels to achieve maximum secretion. A set of signal sequence vectors provides a range of translational strengths for optimizing expression of a polypeptide of interest.

Claims

1. A method of secreting a heterologous polypeptide of interest in a cell comprising using a translational initiation region variant operably linked to nucleic acid encoding said heterologous polypeptide to express said heterologous polypeptide, wherein the translational strength of said variant translational initiation region is less than the translational strength of the wild-type translational initiation region and wherein the amino acid sequence of said translational initiation region variant is not altered.

2. A method according to claim 1, wherein the amount of secreted polypeptide when said nucleic acid is operably linked to said variant is greater than the amount of secreted polypeptide when said nucleic acid is operably linked to a wild-type translation initiation region.

3. A method according to claim 1, wherein said translation initiation region includes a prokaryotic secretion signal sequence.

4. A method according to claim 3, wherein said secretion signal sequence is selected from the group consisting of STII, OmpA, PhoE, LamB, MBP and PhoA.

5. A method according to claim 4, wherein said signal sequence is selected from the group consisting of STII, PhoE and LamB.

6. A method according to claim 5 wherein said signal sequence is STII.

7. A method according to claim 6, wherein said variant is selected from the group consisting of:

5'"'"'-TCTAGAGGTTGAGGTGATTTT ATG AAA AAG AAT ATC GCA TTT CTT CTT GCA TCT ATG TTC GTT TTT TCT ATT GCT ACA AAC GCS TAT GCM 3'"'"' (SEO ID NO;

15, wherein Y at position 81 is C);

5'"'"'-TCTAGAGGTTGAGGTGATTTT ATG AAA AAG AAT ATC GCA TTT CTT CTT GCA TCT ATG TTC GTT TTT TCT ATT GCT ACA AAY GCG TAT GCM 3'"'"'. (SEQ ID NO;

15, wherein S at position 84 is G);

5'"'"'-TCTAGAGGTTGAGGTGATTTT ATG AAA AAG AAT ATC GCA TTT CTT CTT GCA TCT ATG TTC GTT TTT TCT ATT GCT ACA AAY GCS TAT GCC 3'"'"', (SEQ ID NO;

15, wherein M at position 90 is C);

5'"'"' TCTAGAATT ATG AAA AAG AAT ATC GCA TTT CTT CTT GCA TCT ATG TTC GTT TTT TCT ATT GCT ACA AAC GCG TAT GCM 3'"'"' (SEQ ID NO;

16);

5'"'"' TCTAGAATT ATG AAG AAG AAT ATT GCG TTC CTA CTT GCC TCT ATG TTT GTC TTT TCT ATA GCT ACA AAC GCG TAT GCM 3'"'"' (SEQ ID NO;

17);

5'"'"' TCTAGAATT ATG AAG AAG AAT ATC GCA TTT CTT CTT GCA TCT ATG TTC OTT TTT TCT ATT GCT ACA AAC GCG TAT GCM 3'"'"' (SEQ ID NO;

18);

5'"'"' TCTAGAATT ATG AAA AAA AAC ATC GCA TTT CTT CTT GCA TCT ATG TTC GTT TTT TCT ATT GCT ACA AAC GCG TAT GCM 3'"'"' (SEQ ID NO;

19);

5'"'"' TCTAGAATT ATG AAA AAA AAC ATT GCC TTT CTT CTT GCA TCT ATG TTC GTT TTT TCT ATT GCT ACA AAC GCG TAT GCM 3'"'"' (SEQ ID NO;

20);

5'"'"' TCTAGAATT ATG AAG AAA AAC ATC GCT TTT CTT CTT GCA TCT ATG TTC GTT TTT TCT ATT GCT ACA AAC GCG TAT GCM 3'"'"' (SEQ ID NO;

21);

5'"'"' TCTAGAATT ATG AAA AAG AAC ATA GCG TTT CTT CTT GCA TCT ATG TTC GTT TTT TCT ATT GCT ACA AAC GCG TAT GCM 3'"'"' (SEQ ID NO;

22); and

5'"'"' TCTAGAGGTTGAGGTGATTTT ATG AAA AAA AAC ATC GCA TTT CTT CTT GCA TCT ATG TTC GTT TTT TCT ATT GCT ACA AAC GCG TAT GCM 3'"'"' (SEQ ID NO;

23).

8. A method according to claim 5 wherein said signal sequence is LamB.

9. A method according to claim 5 wherein said signal sequence is PhoE.

10. A nucleic acid encoding a translational initiation region variant, wherein the translational strength of said variant translational initiation region is less than the translational strength of the wild-type translational initiation region, wherein said translation initiation region includes a prokaryotic secretion signal sequence selected from the group consisting of OmpA, PhoE, MBP and PhoA.

18. An expression vector comprising the nucleic acid of claim 10 or 11 operably linked to additional elements for expression of a gene of interest.

19. A host cell comprising the expression vector of claim 18.

20. A host cell comprising the nucleic acid of claim 10 or 11.

11. A nucleic acid encoding a polypeptide operably linked to a translational initiation region variant, wherein the translational strength of said variant translational initiation region is less than the translational strength of the wild-type translational initiation region, wherein the amino acid sequence of said translational initiation region variant is not altered.

12. A nucleic acid according to claim 11, wherein said translation initiation region includes a prokaryotic secretion signal sequence.

13. A nucleic acid according to claim 12, wherein said translation initiation region includes a signal sequence selected from the group consisting of STII, OmpA, PhoE, LamB, MBP and PhoA.

14. A nucleic acid according to claim 13, wherein said signal sequence is selected from the group consisting of STII, PhoE and LamB.

15. A nucleic acid according to claim 14 wherein said signal sequence is STII.

16. A nucleic acid according to claim 14 wherein said signal sequence is LamB.

17. A nucleic acid according to claim 14 wherein said signal sequence is PhoE.

21. A method of secreting a heterologous polypeptide of interest in a cell comprising using a translational initiation region variant operably linked to nucleic acid encoding said heterologous polypeptide to express said heterologous polypeptide, wherein the translational strength of said variant translational initiation region is less than the translational strength of the wild-type translational initiation region wherein said translation initiation region includes a prokaryotic secretion signal sequence selected from the group consisting of OmpA, PhoE, MBP and PhoA.